References
1. Zhang L, Fan Y, Wang X, et al. Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors. Frontiers in oncology 2020; 10: 554331.
2. Amaddeo G, Cao Q, Ladeiro Y, et al. Integration of tumour and viral genomic characterizations in HBV-related hepatocellular carcinomas. Gut 2015; 64: 820-9.
3. Tang A, Cruite I, Mitchell DG, et al. Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ. Abdominal radiology (New York) 2018; 43: 3-12.
4. Luo P, Wu S, Yu Y, et al. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage. Pathol Oncol Res 2020; 26: 599-603.
5. Pezzuto F, Buonaguro L, Buonaguro FM, et al. The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma. Int J Mol Sci 2018;19:1007.
6. Wong CM, Tsang FH, Ng IO. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nature reviews Gastroenterology & hepatology 2018; 15: 137-51.
7. Zhao XF, Li N, Lin DD, et al. Circulating MicroRNA-122 for the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis. BioMed research international 2020; 2020: 5353695.
8. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 2009; 6: e1000097.
9. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of internal medicine 2011; 155: 529-36.
10. Swets JA. Measuring the accuracy of diagnostic systems. Science (New York, NY) 1988; 240: 1285-93.
11. Cao X, Yang Q, Yu Q. Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma. Open forum infectious diseases 2020; 7: ofaa498.
12. Chen S, Chen H, Gao S, et al. Differential expression of plasma microRNA-125b in hepatitis B virus-related liver diseases and diagnostic potential for hepatitis B virus-induced hepatocellular carcinoma. Hepatol Res 2017; 47: 312-20.
13. Chen Y, Dong X, Yu D, et al. Serum miR-96 is a promising biomarker for hepatocellular carcinoma in patients with chronic hepatitis B virus infection. International journal of clinical and experimental medicine 2015; 8: 18462-8.
14. Ghosh A, Ghosh A, Datta S, et al. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. International journal of cancer 2016; 138: 2732-44.
15. Li L, Guo Z, Wang J, et al. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Digestive diseases and sciences 2012; 57: 2910-6.
16. Li LM, Hu ZB, Zhou ZX, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma. Cancer research 2010; 70: 9798-807.
17. Li X, Guo Y, Wang X, et al. Clinical significance of serum miR-487b in HBV-related hepatocellular carcinoma and its potential mechanism. Infectious diseases (London, England) 2021; 53: 546-54.
18. Lin L, Lu B, Yu J, et al. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Clinics and research in hepatology and gastroenterology 2016; 40: 397-404.
19. Moradi N, Paryan M, Khansarinejad B, et al. Plasma Level of miR-5193 as a Novel Biomarker for Diagnosis of HBV-Related Hepatocellular Carcinoma. Hepat Mon 2019; 19: e84455.
20. Qi P, Cheng SQ, Wang H, et al. Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PloS one 2011; 6: e28486.
21. Tan Y, Ge G, Pan T, et al. A serum microRNA panel as potential biomarkers for hepatocellular carcinoma related with hepatitis B virus. PloS one 2014; 9: e107986.
22. Xie Y, Yao Q, Butt AM, et al. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Cancer biology & therapy 2014; 15: 1248-55.
23. Xiong F, Ma H, Qu YC, et al. Profiles of serum miR-99a, let-7c and miR-125b in hepatitis B virus (HBV)-associated chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Int J Clin Exp Pathol 2016;9(7):7087-95.
24. Xu LJ, Wei B, Hui HX, et al. Association of serum microRNA-125b and HBV-related hepatocellular carcinoma in Chinese Han patients. Int J Clin Exp Med 2018;11(4):3699-703.
25. Yu F, Lu Z, Chen B, et al. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Diagnostic pathology 2015; 10: 129.
26. Zhang W, Fu T, Guo Z, et al. Serum miR-375 Levels Are Closely Related to Disease Progression from HBV Infection to HBV-Related Hepatocellular Carcinoma. BioMed research international 2020; 2020: 5819385.
27. Zhao Q, Sun X, Liu C, et al. Expression of the microRNA-143/145 cluster is decreased in hepatitis B virus-associated hepatocellular carcinoma and may serve as a biomarker for tumorigenesis in patients with chronic hepatitis B. Oncology letters 2018; 15: 6115-22.
28. Zhou J, Yu L, Gao X, et al. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Journal of clinical oncology 2011; 29: 4781-8.
29. Zhu HT, Liu RB, Liang YY, et al. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Liver international 2017; 37: 888-96.
30. Crotty M, Gnanamanickam ES, Cameron I, et al. Are people in residential care entitled to receive rehabilitation services following hip fracture? Views of the public from a citizens' jury. BMC Geriatr 2020; 20: 172-.
31. Peng C, Li Z, Xie Z, et al. The role of circulating microRNAs for the diagnosis of hepatitis B virus-associated hepatocellular carcinoma with low alpha-fetoprotein level: a systematic review and meta-analysis. BMC gastroenterology 2020; 20: 249.
32. Yin H, Sun Y, Wang X, et al. Progress on the relationship between miR-125 family and tumorigenesis. Experimental cell research 2015; 339: 252-60.
33. Gong J, Zhang JP, Li B, et al. MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene 2013; 32: 3071-9.
34. Li J, Fang L, Yu W, et al. MicroRNA-125b suppresses the migration and invasion of hepatocellular carcinoma cells by targeting transcriptional coactivator with PDZ-binding motif. Oncol Lett 2015; 9: 1971-5.
35. Hua S, Quan Y, Zhan M, et al. miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1. Cancer cell international 2019; 19: 203.
36. Zheng J, Zhou Z, Xu Z, et al. Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression. Molecular medicine reports 2015; 12: 1584-90.
37. Jin X, Cai C, Qiu Y. Diagnostic Value of Circulating microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Journal of Cancer 2019; 10: 4754-64.